awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33267359-0448E73A-DE48-4B23-8FD9-DA7368BE2A49
Q33267359-0448E73A-DE48-4B23-8FD9-DA7368BE2A49
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33267359-0448E73A-DE48-4B23-8FD9-DA7368BE2A49
A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer.
P2860
Q33267359-0448E73A-DE48-4B23-8FD9-DA7368BE2A49
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33267359-0448E73A-DE48-4B23-8FD9-DA7368BE2A49
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
91c4fe51807ee570658ba7889533cd8d3bbeefd2
P2860
Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma.